Related Experiment Video
Updated: Aug 8, 2026

The Soft Agar Colony Formation Assay
Published on: October 27, 2014
WT1-mediated growth suppression of Wilms tumor cells expressing a WT1 splicing variant
D A Haber1, S Park, S Maheswaran
1Laboratory of Molecular Genetics, Massachusetts General Hospital Cancer Center, Boston 02129.
Abstract:
A human Wilms tumor cell line (RM1) was developed to test the tumor suppressor activity of WT1, a zinc finger transcription factor that is expressed in the developing human kidney and is mutationally inactivated in a subset of Wilms tumors. Transfection of each of four wild-type WT1 isoforms suppressed the growth of RM1 cells. The endogenous WT1 transcript in these cells was devoid of exon 2 sequences, a splicing alteration that was also detected in varying amounts in all Wilms tumors tested but not in normal kidney. Production of this abnormal transcript, which encodes a functionally altered protein, may represent a distinct mechanism for inactivating WT1 in Wilms tumors.
Insights
Researchers tested the tumor suppressor WT1 (Wilms tumor 1) in a human Wilms tumor cell line. They found a specific WT1 gene alteration in tumor cells, suggesting a new mechanism for Wilms tumor development.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- Wilms tumor is a pediatric kidney cancer.
- WT1 (Wilms tumor 1) is a gene crucial for kidney development.
- Mutations in WT1 are linked to Wilms tumor development.
Purpose of the Study:
- To investigate the tumor suppressor activity of WT1.
- To analyze WT1 gene expression in Wilms tumor cells.
Main Methods:
- Developed a human Wilms tumor cell line (RM1).
- Transfected RM1 cells with wild-type WT1 isoforms.
- Analyzed WT1 transcript splicing in tumor cells and normal kidney tissue.
Main Results:
- WT1 isoforms suppressed RM1 cell growth.
- A specific splicing alteration (lacking exon 2) was found in endogenous WT1 transcripts in RM1 cells.
- This alteration was present in varying amounts in all tested Wilms tumors but not in normal kidney tissue.
Conclusions:
- The identified WT1 splicing alteration produces a functionally altered protein.
- This abnormal transcript may represent a novel mechanism for WT1 inactivation in Wilms tumors.
More Related Videos
10:51A Possible Zebrafish Model of Polycystic Kidney Disease: Knockdown of wnt5a Causes Cysts in Zebrafish Kidneys
Published on: December 2, 2014
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
Related Concept Videos
Canonical Wnt Signaling Pathway
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...